Viewing Study NCT04530656


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-25 @ 9:19 PM
Study NCT ID: NCT04530656
Status: COMPLETED
Last Update Posted: 2022-06-01
First Post: 2020-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module